Dataset Information

CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

ABSTRACT: Basal-like breast cancers (BLBC), of which many are triple negative, have poor outcomes due to the limited targeted therapies available for patients. To address this need, we examined the clinical correlates and functional properties of CREB5, a transcription factor commonly amplified or overexpressed in other metastatic cancers. Using transcriptomic data from TCGA and METABRIC, we found BLBCs harbored the highest levels of CREB5 expression compared to other BC subtypes and that CREB5-high tumors had poor outcomes. In patient-matched primary and metastatic biopsies, CREB5 expression was robust and further increased in BLBCs that develop brain metastasis. CREB5 overexpression in 2 BLBC cell lines increased cell viability, formation of tumorspheres, and led to substantial increases in mRNA and cell surface expression of IL13RA2, a stem cell-like gene in brain cancers. IL13RA2 is a current CAR-T cell target in gliomas, and our work nominates IL13RA2 as a novel potential target in BLBCs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE283312 | GEO | 2025/08/01

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Triple-negative breast cancer is characterized by absence of oestrogen receptor, progesterone receptor, and a lack of HER2 amplification and is associated with poor patient prognosis and high rates of distant metastasis. These patients are at elevated risk of brain metastasis, which remains a major therapeutic challenge. IL13RA2, a high-affinity receptor for IL13, is highly expressed in primary brain cancers, many extracranial solid tumours, and in lung- and brain-seeking metastatic variant cell lines. However, the relationship between IL13RA2 and patient prognosis is variable, and the biological function of this receptor in cancer remains controversial. We sought to define the role of IL13RA2 in TNBC growth and metastasis, with an emphasis on breast-to-brain metastasis. We identified a positive correlation between elevated IL13RA2 mRNA expression and overall survival in a publicly available dataset of basal-like breast cancer patients. We generated IL13RA2-CRISPR knockout derivatives of the human brain-seeking breast cancer cell line MDA231BrM2 as well as murine 4T1 cells and evaluated changes in gene expression, proliferation, survival, and metastatic growth in vivo. We find that both IL13RA2-deficient models demonstrate enhanced survival and proliferation in vitro, as well as augmented metastatic tumour growth and worsened survival in intracardiac models of brain metastasis. Mechanistically, we observe increased AKT and NF-κB signalling in IL13RA2-deficient cells, which renders these cells highly sensitive to inhibition of AKT. We conclude that, in triple negative breast cancer, loss of IL13RA2 in tumour cells is strongly pro-metastatic, antiapoptotic, and pro-proliferative. These phenotypes are mediated through the AKT and NF-κB pathways. IL13RA2-deficient cells are highly vulnerable to AKT inhibition, which may represent a clinically useful vulnerability for patients with IL13RA2-low tumours. However, our data suggest that inhibition of IL13RA2, though promising in other tumour contexts, may be deleterious in metastatic triple-negative breast cancer.

Dataset Information

CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets